Aetna Given Consensus Recommendation of “Buy” by Analysts (NYSE:AET)
Aetna (NYSE:AET) has been given a consensus rating of “Buy” by the twenty-one brokerages that are currently covering the stock, American Banking & Market News reports. Six research analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $81.06.
Aetna (NYSE:AET) opened at 82.05 on Friday. Aetna has a one year low of $60.32 and a one year high of $82.49. The stock’s 50-day moving average is $78.29 and its 200-day moving average is $72.41. The company has a market cap of $29.325 billion and a P/E ratio of 14.44.
Aetna (NYSE:AET) last released its earnings data on Thursday, April 24th. The company reported $1.98 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.55 by $0.43. The company had revenue of $13.97 billion for the quarter, compared to the consensus estimate of $13.69 billion. During the same quarter in the prior year, the company posted $1.50 earnings per share. The company’s quarterly revenue was up 46.9% on a year-over-year basis. Analysts expect that Aetna will post $6.53 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, July 25th. Investors of record on Thursday, July 10th will be paid a dividend of $0.225 per share. This represents a $0.90 annualized dividend and a dividend yield of 1.10%. The ex-dividend date is Tuesday, July 8th.
In other Aetna news, Director Molly Joel Coye sold 1,650 shares of the stock on the open market in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $80.60, for a total value of $132,990.00. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Several analysts have recently commented on the stock. Analysts at Sterne Agee initiated coverage on shares of Aetna in a research note on Friday. They set a “neutral” rating and a $87.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Aetna in a research note on Thursday, June 19th. They now have a $85.00 price target on the stock. Finally, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Aetna in a research note on Wednesday, June 18th. They now have a $82.00 price target on the stock, up previously from $81.00.
Aetna Inc (NYSE:AET), is a diversified healthcare benefits company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.